Unity Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch UNBX and buy or sell other stocks, ETFs, and their options commission-free!

About UNBX

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. 

CEO
Craig R. Jalbert
CEOCraig R. Jalbert
Employees
16
Employees16
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2009
Founded2009
Employees
16
Employees16

UNBX Key Statistics

Market cap
1.20M
Market cap1.20M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
—
Dividend yield—
Average volume
140.99K
Average volume140.99K
High today
$0.082
High today$0.082
Low today
$0.0683
Low today$0.0683
Open price
$0.0701
Open price$0.0701
Volume
124.30K
Volume124.30K
52 Week high
$3.10
52 Week high$3.10
52 Week low
$0.0487
52 Week low$0.0487

People also own

Based on the portfolios of people who own UNBX. This list is generated using Robinhood data, and it’s not a recommendation.
OPKO Health
Agenus
MiNK Therapeutics
Assertio
AquaBounty
Catalyst Pharmaceuticals
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.